PRPH
Basic information
Region (hg38): 12:49295147-49298686
Previous symbols: [ "NEF4" ]
Links
Phenotypes
GenCC
Source:
- amyotrophic lateral sclerosis (Limited), mode of inheritance: AD
- amyotrophic lateral sclerosis type 1 (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRPH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 47 | 51 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 0 | |||||
non coding | 8 | |||||
Total | 0 | 2 | 50 | 8 | 11 |
Variants in PRPH
This is a list of pathogenic ClinVar variants found in the PRPH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-49295177-G-C | Benign (Sep 29, 2018) | |||
12-49295178-G-C | not provided (-) | |||
12-49295205-G-C | Inborn genetic diseases | Uncertain significance (May 06, 2024) | ||
12-49295216-T-C | Inborn genetic diseases | Uncertain significance (Aug 30, 2022) | ||
12-49295217-C-T | Inborn genetic diseases | Uncertain significance (Jun 24, 2022) | ||
12-49295226-G-A | not specified • Amyotrophic lateral sclerosis type 1 | Benign (May 01, 2024) | ||
12-49295263-C-T | PRPH-related disorder | Likely benign (Oct 18, 2021) | ||
12-49295269-A-G | Likely benign (May 18, 2018) | |||
12-49295304-C-G | Inborn genetic diseases | Uncertain significance (Apr 06, 2023) | ||
12-49295346-C-T | Inborn genetic diseases | Uncertain significance (Jun 30, 2023) | ||
12-49295367-G-C | Inborn genetic diseases | Uncertain significance (Nov 27, 2024) | ||
12-49295390-C-T | Amyotrophic lateral sclerosis | Uncertain significance (Mar 31, 2020) | ||
12-49295390-C-CGAGCGG | Uncertain significance (Jul 28, 2022) | |||
12-49295399-G-C | Inborn genetic diseases | Uncertain significance (Oct 17, 2024) | ||
12-49295428-GC-G | Amyotrophic lateral sclerosis, susceptibility to | risk factor (Oct 29, 2004) | ||
12-49295438-T-G | Inborn genetic diseases | Uncertain significance (Aug 14, 2024) | ||
12-49295441-T-C | Inborn genetic diseases | Uncertain significance (Sep 09, 2024) | ||
12-49295448-C-T | Uncertain significance (Apr 16, 2021) | |||
12-49295456-C-T | Uncertain significance (Mar 22, 2023) | |||
12-49295512-CA-C | Uncertain significance (Oct 31, 2022) | |||
12-49295526-C-T | Inborn genetic diseases | Uncertain significance (Jan 24, 2023) | ||
12-49295552-C-A | Benign (Aug 02, 2018) | |||
12-49295564-A-G | Amyotrophic lateral sclerosis type 1 | Uncertain significance (-) | ||
12-49295583-A-T | Inborn genetic diseases | Uncertain significance (Dec 11, 2023) | ||
12-49295594-G-A | Inborn genetic diseases | Uncertain significance (Apr 24, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PRPH | protein_coding | protein_coding | ENST00000257860 | 9 | 5431 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.79e-14 | 0.0264 | 124482 | 6 | 1260 | 125748 | 0.00505 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.556 | 245 | 271 | 0.905 | 0.0000141 | 2987 |
Missense in Polyphen | 98 | 102.02 | 0.96057 | 1111 | ||
Synonymous | 0.163 | 121 | 123 | 0.981 | 0.00000620 | 965 |
Loss of Function | 0.171 | 21 | 21.9 | 0.961 | 0.00000100 | 241 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00101 | 0.000999 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000986 | 0.000979 |
Finnish | 0.0223 | 0.0221 |
European (Non-Finnish) | 0.00631 | 0.00630 |
Middle Eastern | 0.000986 | 0.000979 |
South Asian | 0.000766 | 0.000752 |
Other | 0.00261 | 0.00261 |
dbNSFP
Source:
- Function
- FUNCTION: Class-III neuronal intermediate filament protein.;
- Pathway
- Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human);Amyotrophic lateral sclerosis (ALS)
(Consensus)
Recessive Scores
- pRec
- 0.412
Intolerance Scores
- loftool
- 0.394
- rvis_EVS
- 0.02
- rvis_percentile_EVS
- 55.45
Haploinsufficiency Scores
- pHI
- 0.188
- hipred
- Y
- hipred_score
- 0.591
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.769
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prph
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- Cellular component
- intermediate filament;membrane;type III intermediate filament;extracellular exosome
- Molecular function
- structural molecule activity;protein binding